Lymphadenectomy for the management of endometrial cancer

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Frost, Jonathan A ^a   Webster, Katie E ^b   Bryant, Andrew ^c   Morrison, Jo ^d  

^a GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER STAGING; CLINICAL EFFECTIVENESS; CYSTIC LYMPHANGIOMA; ENDOMETRIUM CANCER; EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; REVIEW; SURGICAL APPROACH; SURGICAL RISK; SYSTEMATIC REVIEW; ADULT; ADVERSE EFFECTS; DISEASE FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; LYMPH NODE METASTASIS; LYMPHOCELE; META ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; LYMPHOCELE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84962294574     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007585.pub3     Document Type: Review

References (78)

1. Fayallah EA, Hemida RA, Gamal AM, Abd Elhady E, Anwar KI, Nada NA, et al. Pretreatment study of P53 overexpression for selection of candidates for pelvic lymphadenectomy in clinical stage I endometrial carcinoma: a randomized-controlled study. Archives of Gynecology and Obstetrics 2011;283(3):617-22.
2. Kitchener H. ASTEC - A study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecologic Oncology 2006;101(1 Suppl 1):S21-2, Abstract 45.
3. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373(9658):125-36.
4. Kitchener HC, Redman CW, Swart AMC, Amos CL. Astec (Surgery Component): a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer (Isrctn 16571884): 00094. International Journal of Gynecological Cancer 2005;15:77.
5. Panici PB, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Journal of the National Cancer Institute 2008;100(23):1707-16.
6. Panici PB, Basile S, Salerno MG, Di Donato V, Marchetti C, Perniola G, et al. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. American Journal of Obstetrics & Gynecology 2014;210:363e1-363e10.
7. Panici PB, Frigerio L, Sardi J, Campagnutta E, Scambia G, Tateo S, et al. Feasibility and complications of systematic lymphadenectomy in endometrial cancer. preliminary results of a prospective randomized multicentric clinical trial. International Journal of Gynecological Cancer 1999;9:88-9.
8. Panici PB, Maneschi F, Cutillo G. Pelvic and aortic lymphadenectomy. Surgical Clinics of North America 2001;81(4):841-58.
9. Panici PB, Tateo S, Mangili G, Scambia G, Garozzo G, Pelusi G, et al. Complications of lymphadenectomy in endometrial cancer. results of a prospective randomized multicentric clinical trial. International Journal of Gynecological Cancer 2004;14:6.
10. Angoli R, Plotti F, Cafa E, Dugo N, Caprigione S, Corrado T, et al. Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013;170:539-43.
11. Ansari M, Ghodsi Rad MA, Hassanzadeh M, Gholami H, YousefiZ, Dabbagh VR, et al. Sentinel node biopsy in endometrial cancer: systematic review and meta-analysis of the literature. European Journal of Gynaecological Oncology 2013;34:387-401.
12. Babilonti L, Di Pietro G, La Fianza A, Beretta P, Franchi M. Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. European Journal of Gynaecological Oncology 1989;10(2):131-3.
13. Barton DP, Naik R, Herod J. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study. International Journal of Gynaecological Cancer 2009;19(8):1465.
14. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. Journal of Obstetrics and Gynaecology Research 2014;40:301-11.
15. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12, 333 patients. Cancer 2006;107(6):1823-30.
16. Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. European Journal of Cancer 2012;48(6):853-64.
17. Fujimoto T, Tanaka T. Evaluation of the efficacy of systematic pelvic lymphadenectomy in endometrial cancer. Future Oncology 2009;5(4):459-63.
18. Gao M, Gao YN, Yan X, Zheng H, Jiang GQ, Wang W, et al. Evaluation of complications of different operation modes in endometrial cancer [Chinese]. Chinese Journal of Oncology 2013;35:932-5.
19. Havrilesky LJ, Chino JP, Myers ER. How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis. Gynecologic Oncology 2013;131:140-6.
20. Hofstetter G, Alektiar K, Leitao MM, Hensley ML, Soslow RA, Zivanovic O, et al. Does removal of a positive sentinel node without lymphadenectomy impact pelvic sidewall control in endometrial cancer?. Gynecologic Oncology 2014;Conference:193-4.
21. Huh WK, Crim A, Petro KN, Irons AE, Samples KL, Alvarez RD, et al. Specimen labelling and processing impacts pelvic lymph node yield: results of a randomized controlled trial. Gynecologic Oncology 2008;108(3 Suppl 1):S64, Abstract 143.
22. Kang WD, Kim CH, Cho MK, Kim JW, Kim YH, Choi HS, et al. Lymphadenectomy for low-risk endometrial cancer based on preoperative and intraoperative assessments. International Journal of Gynecological Cancer 2009;19(4):657-61.
23. Kim HS, Suh DH, Kim MK, Chung HH, Park NH, Song YS. Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis. Japanese Journal of Clinical Oncology 2012;42(5):405-12.
24. Kitchener H. The effect of incision in the surgical treatment of endometrial cancer and long-term follow-up of a randomized trial of lymphadenectomy: results of the MRC ASTEC trial. Journal of Clinical Oncology 2011;29(Suppl):Abstract e15583.
25. Kitchener H. Lymphadenectomy for endometrial cancer. Why we still need a trial. International Journal of Gynecological Cancer 2013;23(Suppl 1):19.
26. Kyrgiou M, Warwick J, Swart AM, Qian W, Ghaem-Maghami S, Kitchener H. Laparoscopic versus open hysterectomy for endometrial cancer: the ASTEC trial. Reproductive Sciences 2013;Conference:339A.
27. Kyrgiou M, Warwick J, Swart AM, Qian W, Ghaem-Maghami S, Kitchener H. Laparoscopic versus open hysterectomy for endometrial cancer: the ASTEC trial. Reproductive Sciences 2013;20(3 Suppl):339A.
28. Lamela EM, Jesus MV, Veronica SM, Carmen GP, Yolanda EL, Teresa RR. Complications and long-term results after laparoscopy for stage endometrial cancer. Gynecological Surgery 2013;10(Suppl 1):S57.
29. Look KY. Role of lymphadenectomy in management of adenocarcinoma of the endometrium. European Journal of Gynaecological Oncology 2004; Vol. 25, issue 5:545-51.
30. Mannel RS, Berman ML, Walker JL, Disaia PJ. Initial surgical therapy in the management of clinical stage II. endometrial cancer. Gynecologic Oncology 1989;32(1):105.
31. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecologic Oncology 2000;76(3):348-56.
32. Mosgaard BJ, Skovlund VR, Hendel HW. Promising results using sentinel node biopsy as a substitute for radical lymphadenectomy in endometrial cancer staging. Danish Medical Journal 2013;60(7):A4665.
33. Nahhas WA, Whitney CW, Stryker JA, Curry SL, Chung CK, Mortel R. Stage II. endometrial carcinoma. Gynecologic Oncology 1980;10(3):303-11.
34. Obermair A, Janda M, Baker J, Kondalsamy-Chennakesavan S, Brand A, Hogg R, et al. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. European Journal of Cancer 2012;48:1147-53.
35. Poll-Franse LV, Pijnenborg JM, Boll D, Vos MC, Berg H, Lybeert ML, et al. Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study. Gynecologic Oncology 2012;127:153-60.
36. Puente R, Schneider E, Carpio D, Benavides T. It's important the surgery performed in low-risk and intermediate-risk of endometrial cancer in relation to relapsed disease and recurrence sites?. International Journal of Gynecological Cancer 2011;21(Suppl 3 12):S1184.
37. Quinn MA. Complete pelvic lymphadenectomy in 'high-risk' endometrial carcinoma. International Journal of Gynecological Cancer 1993;3(Suppl 1):28.
38. Rodolakis A, Thomakos N, Vlachos G, Haidopoulos D, Sarris K, Sotiropoulou M, et al. Lymphadenectomy in apparent early-stage endometrial cancer - Clinical utility and cost effectiveness. Gynecologic Oncology 2012;125(Suppl 1):S150.
39. Rossi EC, Jackson A, Ivanova A, Boggess JF. Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection. International Journal of Gynecological Cancer 2013;23:1704-11.
40. Rossi EC, Jackson AL, Kowalski LD, Ivanova A, Boggess JF. The sensitivity of sentinel lymph nodes identified with robotic fluorescence imaging for detecting metastatic endometrial cancer: interim results from the FIRES trial. Gynecologic Oncology 2014;133:22-3.
41. Rubin SC, Hoskins WJ, Nori D, Mychalczak B, Almadrones L, Chapman D, et al. Management of stage II. endometrial adenocarcinoma. Gynecologic Oncology 1990;36(2):294.
42. Salvesen HB. Role of lymphadenectomy in the surgery of gynecologic cancer. Tidsskr Nor Laegeforen 2001;121(10):1240-5.
43. Schulz KD. Adjuvant treatment of endometrial carcinoma. Journal of Cancer Research & Clinical Oncology 1986;111(S6):Abstract ThT 05.
44. Shan B, Ren Y, Tu X, Jiang Z, Sun M, Cheng X, et al. Sentinel lymph nodes mapping and micrometastases detection in patients with early-stage endometrial cancer. International Journal of Gynecological Cancer 2013;23(Suppl 1):333.
45. Bijen CB, de Bock GH, Mourits MJ. Total laparoscopic versus abdominal hysterectomy with lymphadenectomy for early stage endometrial cancer: a prospective randomized study: author reply. Gynecologic Oncology 2009;113(2):295-6.
46. Tong SY, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, et al. Efficacy of para-aortic lymphadenectomy in early-stage endometrioid uterine corpus cancer. Annals of Surgical Oncology 2011;18(5):1425-30.
47. Trovik J, Wik E, Werner HM, Krakstad C, Helland H, Vandenput I, et al. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. European Journal of Cancer 2013;49(16):3431-41.
48. Turkler C, Gokcu M, Ozeren M, Sanci M. Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients. International Journal of Gynecological Cancer 2013;23(Suppl 1):422.
49. Watari H, Todo Y, Kang S, Odagiri T, Sakuragi N. Proposal of a concept and design of a randomized phase III. trial investigating the survival effect of para-aortic lymphadenectomy in endometrial cancer. Journal of Obstetrics and Gynaecology Research 2014;40(2):312-6.
50. Zapico A, Pedro V, Aldina C, Irene H, Victoria M, Del Pedro F, et al. Sentynel lymph node biopsy and endometrial cancer. Gynecological Surgery 2013;10(Suppl 1):S53.
51. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta- analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50:683-91.
52. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; Vol. 60, issue 8 Suppl:2035-41.
53. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
54. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
55. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: IARC Press, 2013.
56. GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328:1490-4.
57. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
58. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011.
59. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecologic Oncology 2011;123(3):522-7.
60. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecologic Oncology 1995; Vol. 56, issue 1:29-33.
61. Kim YB, NiloffJM. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstetrics and Gynecology 1993; Vol. 82, issue 2:175-80.
62. Kitchener H, Swart AM, Qian W, Parmar M. Lymphadenectomy in endometrial cancer - Authors' reply. The Lancet 2009;373(9670):1170-1.
63. Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database of Systematic Reviews 2012, issue Issue, 4, CD003916. DOI: 10.1002/14651858. [2. Art. No.: CD003916. DOI: 10.1002/14651858.CD003916.pub2.]
64. Moher D, Pham D, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
65. NICE. Heavy menstrual bleeding. NICE Clinical Guideline 2007; Vol. CG44:10.
66. Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. International Journal of Cancer 2010;126:490-9.
67. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005; Vol. 55, issue 2:74-108.
68. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998; Vol. 17, issue 24:2815-34. [MEDLINE: 99120172]
69. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynecology & Obstetrics 2009;105(2):103-4.
70. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
71. Rockall A. Diagnostic accuracy of MRI, diffusion-weighted MRI, FDGPET/CT and Fluoro-ethyl-choline PET/CT in the detection of lymph node metastases in surgically staged endometrial and cervical carcinoma. Trial Protocol 2011; Vol. ISRCTN 84527805; UKCRN ID 10984.
72. Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
73. Shepherd JH. Revised FIGO staging for gynaecological cancer. British Journal of Obstetrics and Gynaecology 1989; Vol. 96, issue 8:889-92. [MEDLINE: 89375209]
74. Siegel R, Miller K, Jemal A. Cancer Statistics, 2015. CA: A Cancer Journal for Clinicians 2015;65(1):5-29.
75. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-72.
76. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecologic Oncology 1998; Vol. 71, issue 3:340-3.
77. van Lankveld MA, Koot NC, Peeters PH, van Leeuwen JS, Jurgenliemk-Schulz IM. Compliance to surgical and radiation treatment guidelines in relation to patient outcome in early stage endometrial cancer. Journal of Evaluation in Clinical Practice 2006;12(2):196-201.
78. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007585.pub2]